Mumbai, April 24 -- Revenue from operations jumped 19.49% YoY to Rs 1,720.30 crore in Q4 FY25.

Profit before tax (PBT) soared 191.17% to Rs 312.34 crore during the quarter ended 31st March 2025.

EBITDA stood at Rs 477 crore in Q4 FY25, recording growth of 84%, as compared with Rs 259 crore in Q4 FY24. It includes one-time gain of Rs 59 crore from sale of land in 4Q FY25. EBITDA margin expanded to 27.7% in Q4 FY25 as against 18% in Q4 FY24.

Revenue from CDMO segment jumped 85% to Rs 490 crore in Q4 FY25 as compared with Rs 265 crore in Q4 FY24. In Q4 FY25, revenue from small molecules jumped 95% YoY to Rs 461 crore, driven by several mid-to-late stage NCE deliveries and steady increase in sales from new manufacturing assets. While reven...